125 related articles for article (PubMed ID: 15231451)
1. Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer.
Elahi MM; McMillan DC; McArdle CS; Angerson WJ; Sattar N
Nutr Cancer; 2004; 48(2):171-3. PubMed ID: 15231451
[TBL] [Abstract][Full Text] [Related]
2. Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer.
McMillan DC; Elahi MM; Sattar N; Angerson WJ; Johnstone J; McArdle CS
Nutr Cancer; 2001; 41(1-2):64-9. PubMed ID: 12094630
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival.
Read JA; Choy ST; Beale PJ; Clarke SJ
Nutr Cancer; 2006; 55(1):78-85. PubMed ID: 16965244
[TBL] [Abstract][Full Text] [Related]
4. Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss.
McMillan DC; Watson WS; O'Gorman P; Preston T; Scott HR; McArdle CS
Nutr Cancer; 2001; 39(2):210-3. PubMed ID: 11759282
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer.
Ramsey S; Lamb GW; Aitchison M; Graham J; McMillan DC
Cancer; 2007 Jan; 109(2):205-12. PubMed ID: 17149754
[TBL] [Abstract][Full Text] [Related]
6. Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer.
Crozier JE; Leitch EF; McKee RF; Anderson JH; Horgan PG; McMillan DC
Am J Surg; 2009 Apr; 197(4):544-9. PubMed ID: 18614139
[TBL] [Abstract][Full Text] [Related]
7. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.
Ishizuka M; Nagata H; Takagi K; Kubota K
Ann Surg; 2009 Aug; 250(2):268-72. PubMed ID: 19638907
[TBL] [Abstract][Full Text] [Related]
8. Higher serum C-reactive protein concentration and hypoalbuminemia are poor prognostic indicators in patients with esophageal cancer undergoing radiotherapy.
Wang CY; Hsieh MJ; Chiu YC; Li SH; Huang HW; Fang FM; Huang YJ
Radiother Oncol; 2009 Aug; 92(2):270-5. PubMed ID: 19195729
[TBL] [Abstract][Full Text] [Related]
9. Combined evaluation of the Glasgow prognostic score and carcinoembryonic antigen concentration prior to hepatectomy predicts postoperative outcomes in patients with liver metastasis from colorectal cancer.
Kobayashi T; Kawakamil M; Hara Y; Shioiri S; Yasuno M; Teruya M; Kaminishi M
Hepatogastroenterology; 2014; 61(133):1359-62. PubMed ID: 25436311
[TBL] [Abstract][Full Text] [Related]
10. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG-ps) in patients receiving palliative chemotherapy for gastroesophageal cancer.
Crumley AB; Stuart RC; McKernan M; McDonald AC; McMillan DC
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e325-9. PubMed ID: 17645468
[TBL] [Abstract][Full Text] [Related]
11. Elevated C-reactive protein and hypoalbuminemia measured before resection of colorectal liver metastases predict postoperative survival.
Kobayashi T; Teruya M; Kishiki T; Endo D; Takenaka Y; Miki K; Kobayashi K; Morita K
Dig Surg; 2010; 27(4):285-90. PubMed ID: 20689289
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer.
Canna K; McMillan DC; McKee RF; McNicol AM; Horgan PG; McArdle CS
Br J Cancer; 2004 May; 90(9):1707-9. PubMed ID: 15150596
[TBL] [Abstract][Full Text] [Related]
13. Systemic inflammatory response and survival in patients with localised prostate cancer: 10-year follow-up.
McArdle PA; Qayyum T; McMillan DC
Urol Int; 2010; 84(4):430-5. PubMed ID: 20395655
[TBL] [Abstract][Full Text] [Related]
14. Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer.
Ishizuka M; Nagata H; Takagi K; Horie T; Kubota K
Ann Surg; 2007 Dec; 246(6):1047-51. PubMed ID: 18043109
[TBL] [Abstract][Full Text] [Related]
15. Systemic inflammatory response predicts survival following curative resection of colorectal cancer.
McMillan DC; Canna K; McArdle CS
Br J Surg; 2003 Feb; 90(2):215-9. PubMed ID: 12555298
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an inflammation-based prognostic score in patients with advanced ovarian cancer.
Sharma R; Hook J; Kumar M; Gabra H
Eur J Cancer; 2008 Jan; 44(2):251-6. PubMed ID: 18155897
[TBL] [Abstract][Full Text] [Related]
17. Inflammation-based prognostic score as a predictor of postoperative gastric cancer recurrence.
Mohri Y; Tanaka K; Ohi M; Toiyama Y; Yasuda H; Inoue Y; Uchida K; Kusunoki M
Anticancer Res; 2012 Oct; 32(10):4581-4. PubMed ID: 23060589
[TBL] [Abstract][Full Text] [Related]
18. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.
Proctor MJ; Morrison DS; Talwar D; Balmer SM; Fletcher CD; O'Reilly DS; Foulis AK; Horgan PG; McMillan DC
Eur J Cancer; 2011 Nov; 47(17):2633-41. PubMed ID: 21724383
[TBL] [Abstract][Full Text] [Related]
19. The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer.
Ramsey S; Lamb GW; Aitchison M; McMillan DC
Br J Cancer; 2006 Oct; 95(8):1076-80. PubMed ID: 17003778
[TBL] [Abstract][Full Text] [Related]
20. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones.
Fouladiun M; Körner U; Bosaeus I; Daneryd P; Hyltander A; Lundholm KG
Cancer; 2005 May; 103(10):2189-98. PubMed ID: 15822132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
